Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2009
05/14/2009WO2009059751A1 Diagnostic method for determining an infection caused by or associated with siderophore-secreting microorganisms
05/14/2009WO2009059554A1 Single nucleotide polymorphism in human toll-like receptor 7 gene and its use
05/14/2009WO2009059447A1 A quantitative method for oligonucleotide microarray
05/14/2009WO2009059430A1 Microfluidic device and method of using same
05/14/2009WO2009059425A1 Stat3 inhibitors for the treatment of fibrosis
05/14/2009WO2009059417A1 Association of single nucleotide polymorphisms in the cbfa2t1 and decr1 genes with performance and carcass merit of beef cattle
05/14/2009WO2009059414A1 Mitochondrial dna deletion between about residues 12317-16254 for use in the detection of cancer
05/14/2009WO2009059411A1 Porcine lung epithelial cell line and its use in production and detection of porcine reproductive and respiratory syndrome virus
05/14/2009WO2009040557A3 Polynucleotide primers for detecting pik3ca mutations
05/14/2009WO2009039542A9 Methods of screening for compounds having anti- inflammatory activity and/or prevent / treat vascular leak
05/14/2009WO2009038666A3 Compositions and methods for the identification of inhibitors of retroviral infection
05/14/2009WO2009037402A3 Hpiv-2 variants and medical applications thereof
05/14/2009WO2009035554A3 Superior structure stability and selectivity of hairpin nucleic acid probes with an l-dna stem
05/14/2009WO2009026546A3 Methods of modifying support surfaces for the immobilization of particles and the use of the immobilized particles for analyzing nucleic acids
05/14/2009WO2009025761A3 Methods for identifying bacterial strains that produce l-tyrosine
05/14/2009WO2009013405A3 Human male fertility control using spata 16
05/14/2009WO2009004189A9 Method for measuring the plasmine activity of microparticles present in a sample of a biological fluid and use thereof
05/14/2009WO2008140832A3 Method for rapid detection of clostridium botulinum
05/14/2009WO2008133643A3 Plant micrornas and methods of use thereof
05/14/2009WO2008127291A3 Advanced drug development and manufacturing
05/14/2009WO2008066979A3 Methods for rapid, single-step strand displacement amplification of nucleic acids
05/14/2009WO2008057160A3 Compositions and multiplex assays for measuring biological mediators of physiological health
05/14/2009WO2008036835A3 Methods and compositions for upregulation of peroxiredoxin activity
05/14/2009WO2008021944A3 Potentiation of antifungal compounds
05/14/2009WO2008005777A3 Methods of enhancing protein incorporation into virus like particles
05/14/2009WO2007059120A3 Allelic form of the hmga2 gene predisposing women to the formation of leiomyomas
05/14/2009WO2007056527A3 Diagnostic and therapeutic methods and agents
05/14/2009WO2007056332A3 Molecular diagnosis of autoimmune diseases
05/14/2009WO2007047581A3 Pulmonary stem cells, related methods and kits
05/14/2009WO2007022248A3 Methods of detection of cancer using peptide profiles
05/14/2009WO2007021756A3 Methods for characterizing biological molecule modulators
05/14/2009WO2006131249A8 Method for sequencing nucleic acids and analogues thereof
05/14/2009WO2006130449A3 Method for determining resistance of hiv to nucleoside reverse transcriptase inhibitor treatment
05/14/2009WO2006116197A3 Methods of identifying individuals at risk of perioperative myocardial injury, major adverse cardiac events, cognitive decline, arrhythmias, depression or bleeding
05/14/2009WO2006113429A3 Viral inhibitors
05/14/2009WO2006099365A9 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
05/14/2009WO2006060630A3 Apparatuses and methods for determining protease activity
05/14/2009WO2005113823A3 Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same
05/14/2009WO2005113809A3 Novel fibroblast growth factor and nucleic acids encoding same
05/14/2009WO2005079363A3 Aptamer therapeutics useful in the treatment of complement-related disorders
05/14/2009WO2005003299A3 Polynucleotides encoding novel guanylate binding proteins (gbp's)
05/14/2009WO2004061125A3 Compositions, methods and systems for inferring bovine traits
05/14/2009US20090126046 Plants having improved growth characteristics and method for making the same
05/14/2009US20090126042 for improving fiber quality and/or yield of a fiber producing plant, as well as methods of using such polynucleotides for producing plants having increased biomass/vigor/yield
05/14/2009US20090126041 Regeneration
05/14/2009US20090126039 for plants grown under non-stress growth conditions; preferentially increasing activity in the cytosol of a plant cell of a type I DnaJ-like polypeptide
05/14/2009US20090126037 Tomtato plants having higher levels of resistance to botrytis
05/14/2009US20090126036 Brassica Oleracea Plants with a Resistance to Mycosphaerella Brassicicola
05/14/2009US20090126034 Environmentally Stable Sensors and Methods of Using the Same
05/14/2009US20090126033 Method of selective breeding based on ob genotype
05/14/2009US20090125247 Gene expression markers of recurrence risk in cancer patients after chemotherapy
05/14/2009US20090125245 Methods For Rapid Forensic Analysis Of Mitochondrial DNA
05/14/2009US20090124795 Mitochondrial Dosimeter
05/14/2009US20090124686 Gsk-3 inhibitors
05/14/2009US20090124684 Stimulation Of CPT-1 As A Means To Reduce Weight
05/14/2009US20090124675 Inhibitors of anti-apoptotic proteins
05/14/2009US20090124608 CB2 Receptor Modulators In Neurodegenerative Diseases And Applications Of The Same
05/14/2009US20090124584 Regeneration of vaginal tissue with non-systemic vaginal administration of estrogen
05/14/2009US20090124568 Use of stem cells to generate inner ear cells
05/14/2009US20090124566 Methods and compositions for the treatment of erythrocyte diseases
05/14/2009US20090124555 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents
05/14/2009US20090124542 Methods and reagents for treatment and diagnosis of age-related macular degeneration
05/14/2009US20090124515 Methods and compositions for preparation of selectively protected carbohydrates
05/14/2009US20090124506 Membrane computing
05/14/2009US20090123999 Nucleotide sequences invovled in plant disease resistance
05/14/2009US20090123969 Novel fluorescent protein and gene encoding the same
05/14/2009US20090123963 Biopsy sample mount and processing method
05/14/2009US20090123962 Chemical Sensing Device
05/14/2009US20090123961 Microfluidic device having stable static gradient for analyzing chemotaxis
05/14/2009US20090123960 Method for Removing Antibiotics From Blood Culture Samples
05/14/2009US20090123959 Microorganism discriminator and method
05/14/2009US20090123958 Laboratory Devices, Methods and Systems Employing Acoustic Ejection Devices
05/14/2009US20090123957 Isolation and sequencing of canine COX-1 and COX-2 genes for use in identifying COX-2 specific inhibitors specifically for use in dogs
05/14/2009US20090123956 Measurement of the oxidants-antioxidants balance in liquids
05/14/2009US20090123955 Size Self-Limiting Compositions and Test Devices for Measuring Analytes in Biological Fluids
05/14/2009US20090123954 Multicolor bioluminescent visualization probe set, or single-molecule-format multicolor bioluminescent visualization probe
05/14/2009US20090123953 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
05/14/2009US20090123952 Method of Measuring Amyloid-Beta Peptides
05/14/2009US20090123951 Method Of Diagnosing A Body Weight Condition Or Predisposition
05/14/2009US20090123950 Generation And Profiling Of Fully Human Hucal Gold®-Derived Therapeutic Antibodies Specific For Human CD38
05/14/2009US20090123942 Electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes
05/14/2009US20090123941 Method and kit for detecting the early onset of renal tubular cell injury
05/14/2009US20090123935 Measurement of a population of nucleic acids, in particular by real time PCR
05/14/2009US20090123934 Inhibition of polo kinase by matrimony maintains G2 arrest in the meiotic cell cycle
05/14/2009US20090123933 Microrna biomarkers in lupus
05/14/2009US20090123932 Quantitative test to detect disease progression markers of epithelial ovarian cancer patients
05/14/2009US20090123931 Identification of tissue for debridement
05/14/2009US20090123930 Methods and compositions for diagnostic use in cancer patients
05/14/2009US20090123929 Methods and kits for diagnosing or monitoring autoimmune and chronic inflammatory diseases
05/14/2009US20090123928 Genomic Landscapes of Human Breast and Colorectal Cancers
05/14/2009US20090123927 Isolation of precursor cells and their use for tissue repair
05/14/2009US20090123926 characterized by substantial impairments of the genome, either in its structure, deletion or translocation and methods which allow genes to be located and mapped rapidly
05/14/2009US20090123925 Cancer therapy prognosis and target
05/14/2009US20090123924 Method for Breast Cancer Diagnosis
05/14/2009US20090123923 Method for obtaining information regarding quantity of DNA after non-methylated cytosine converting treatment in analysis of DNA methylation
05/14/2009US20090123922 Bead Bound Combinatorial Oligonucleoside Phosphorothioate And Phosphorodithioate Aptamer Libraries
05/14/2009US20090123921 Immunoglobulin libraries
05/14/2009US20090123920 Jak2 mutations
05/14/2009US20090123919 Diagnosing Pathological Conditions Using Interallelic Epigenetic Variations
05/14/2009US20090123918 Human Protooncogene TRG and Protein Encoded Therein